Cas no 938138-94-4 (2,6-Dichloro-8-methylquinoline-3-carboxaldehyde)

2,6-Dichloro-8-methylquinoline-3-carboxaldehyde is a versatile quinoline derivative characterized by its distinct dichloro and methyl substituents, which enhance its reactivity and utility in organic synthesis. The aldehyde functional group at the 3-position makes it a valuable intermediate for constructing heterocyclic compounds, pharmaceuticals, and agrochemicals. Its electron-withdrawing chloro groups and steric influence from the methyl group contribute to selective reactivity in cross-coupling and condensation reactions. This compound is particularly useful in medicinal chemistry for the development of bioactive molecules due to its structural rigidity and functional group compatibility. High purity and stability under standard conditions further ensure reliable performance in synthetic applications.
2,6-Dichloro-8-methylquinoline-3-carboxaldehyde structure
938138-94-4 structure
Product Name:2,6-Dichloro-8-methylquinoline-3-carboxaldehyde
CAS No:938138-94-4
MF:C11H7Cl2NO
MW:240.085380792618
MDL:MFCD09702833
CID:876489
PubChem ID:329773423
Update Time:2025-11-02

2,6-Dichloro-8-methylquinoline-3-carboxaldehyde Chemical and Physical Properties

Names and Identifiers

    • 2,6-dichloro-8-methylquinoline-3-carbaldehyde
    • 2,6-Dichloro-8-methylquinoline-3-carboxaldehyde
    • 2,6-Dichloro-8-methyl-3-quinolinecarboxaldehyde (ACI)
    • 938138-94-4
    • AB51084
    • 2,6-Dichloro-8-methylquinoline-3-carboxaldehyde, AldrichCPR
    • DTXSID00588939
    • MFCD09702833
    • DB-079716
    • SCHEMBL17603454
    • LQGCPWAESLYAKC-UHFFFAOYSA-N
    • MDL: MFCD09702833
    • Inchi: 1S/C11H7Cl2NO/c1-6-2-9(12)4-7-3-8(5-15)11(13)14-10(6)7/h2-5H,1H3
    • InChI Key: LQGCPWAESLYAKC-UHFFFAOYSA-N
    • SMILES: O=CC1C(Cl)=NC2C(=CC(=CC=2C)Cl)C=1

Computed Properties

  • Exact Mass: 238.99000
  • Monoisotopic Mass: 238.9904692g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 15
  • Rotatable Bond Count: 1
  • Complexity: 249
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 3.6
  • Topological Polar Surface Area: 30?2

Experimental Properties

  • PSA: 29.96000
  • LogP: 3.66250

2,6-Dichloro-8-methylquinoline-3-carboxaldehyde Security Information

  • Symbol: GHS07
  • Signal Word:Warning
  • Hazard Statement: H302
  • Hazardous Material transportation number:NONH for all modes of transport
  • WGK Germany:3
  • Hazard Category Code: 22
  • Hazardous Material Identification: Xn

2,6-Dichloro-8-methylquinoline-3-carboxaldehyde Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd.
BBO000097-1G
2,6-Dichloro-8-methylquinoline-3-carboxaldehyde
938138-94-4
1g
¥3340.6 2023-11-11
TRC
D483753-50mg
2,6-Dichloro-8-methylquinoline-3-carboxaldehyde
938138-94-4
50mg
$ 50.00 2022-06-05
TRC
D483753-100mg
2,6-Dichloro-8-methylquinoline-3-carboxaldehyde
938138-94-4
100mg
$ 65.00 2022-06-05
TRC
D483753-500mg
2,6-Dichloro-8-methylquinoline-3-carboxaldehyde
938138-94-4
500mg
$ 210.00 2022-06-05
Apollo Scientific
OR307886-1g
2,6-Dichloro-8-methylquinoline-3-carboxaldehyde
938138-94-4
1g
£207.00 2025-02-20
Apollo Scientific
OR307886-5g
2,6-Dichloro-8-methylquinoline-3-carboxaldehyde
938138-94-4
5g
£475.00 2025-02-20
abcr
AB213320-250 mg
2,6-Dichloro-8-methylquinoline-3-carboxaldehyde
938138-94-4
250MG
€136.80 2022-06-11
abcr
AB213320-500 mg
2,6-Dichloro-8-methylquinoline-3-carboxaldehyde
938138-94-4
500MG
€192.10 2022-06-11
abcr
AB213320-1 g
2,6-Dichloro-8-methylquinoline-3-carboxaldehyde
938138-94-4
1g
€279.00 2022-06-11
abcr
AB213320-2,5 g
2,6-Dichloro-8-methylquinoline-3-carboxaldehyde
938138-94-4
2,5 g
€460.70 2022-06-11

Additional information on 2,6-Dichloro-8-methylquinoline-3-carboxaldehyde

2,6-Dichloro-8-methylquinoline-3-carboxaldehyde (CAS No. 938138-94-4): A Versatile Building Block in Organic Synthesis

2,6-Dichloro-8-methylquinoline-3-carboxaldehyde (CAS No. 938138-94-4) is a highly specialized quinoline derivative that has gained significant attention in modern organic chemistry and pharmaceutical research. This compound, characterized by its unique chloro-methyl substitution pattern and reactive aldehyde functional group, serves as a crucial intermediate in the synthesis of various biologically active molecules. The molecular structure features a quinoline core with strategic substitutions at the 2,6, and 8 positions, making it particularly valuable for constructing complex heterocyclic systems.

Recent trends in medicinal chemistry have highlighted the importance of functionalized quinoline derivatives like 2,6-Dichloro-8-methylquinoline-3-carboxaldehyde in drug discovery programs. Researchers are particularly interested in its potential applications for developing antimicrobial agents and anticancer compounds, as evidenced by numerous patent filings and publications. The compound's electron-deficient quinoline system combined with the reactive aldehyde moiety allows for diverse chemical transformations, enabling the creation of novel molecular architectures.

From a synthetic chemistry perspective, 2,6-Dichloro-8-methylquinoline-3-carboxaldehyde offers multiple advantages. The chloro substituents at positions 2 and 6 provide excellent sites for nucleophilic aromatic substitution reactions, while the methyl group at position 8 offers steric control in subsequent transformations. The 3-carboxaldehyde functionality serves as a versatile handle for condensation reactions, reductive amination, and heterocycle formation, making this compound a true multifunctional building block.

The growing demand for quinoline-based pharmaceuticals has significantly increased interest in 2,6-Dichloro-8-methylquinoline-3-carboxaldehyde across academic and industrial laboratories. Current research focuses on its use in developing targeted kinase inhibitors, particularly for cancer therapy applications. The compound's structural features allow for precise modification to optimize drug-like properties while maintaining target specificity, addressing one of the key challenges in modern drug development.

Material science applications of 2,6-Dichloro-8-methylquinoline-3-carboxaldehyde are also emerging, particularly in the design of organic electronic materials. The electron-accepting quinoline core, when properly functionalized, can contribute to the development of novel organic semiconductors and photovoltaic materials. Researchers are exploring its incorporation into π-conjugated systems for potential use in OLED devices and organic photodetectors.

Quality control of 2,6-Dichloro-8-methylquinoline-3-carboxaldehyde requires careful attention to purity parameters. Advanced analytical techniques including HPLC analysis, mass spectrometry, and NMR spectroscopy are essential for verifying the compound's identity and assessing impurity profiles. The presence of reactive aldehyde group necessitates proper storage conditions, typically under inert atmosphere at controlled temperatures to prevent degradation.

Recent innovations in synthetic methodology have improved access to 2,6-Dichloro-8-methylquinoline-3-carboxaldehyde, with several research groups reporting optimized routes that enhance yield and purity. Modern catalytic systems and green chemistry approaches are being applied to its production, reflecting the growing emphasis on sustainable chemical synthesis in the pharmaceutical industry.

The commercial availability of 2,6-Dichloro-8-methylquinoline-3-carboxaldehyde has expanded significantly in recent years, with multiple suppliers offering the compound in various quantities. Pricing trends indicate steady demand from both academic research institutions and pharmaceutical development teams. Custom synthesis services have also emerged to provide derivatives and analogs based on this versatile quinoline scaffold.

Future research directions for 2,6-Dichloro-8-methylquinoline-3-carboxaldehyde include exploration of its bioconjugation potential and applications in proteolysis targeting chimera (PROTAC) development. The compound's unique structural features position it well for these cutting-edge therapeutic approaches, which represent some of the most exciting frontiers in drug discovery technology.

In conclusion, 2,6-Dichloro-8-methylquinoline-3-carboxaldehyde (CAS No. 938138-94-4) stands as a remarkably versatile compound with wide-ranging applications across medicinal chemistry, materials science, and organic synthesis. Its unique combination of substituent patterns and reactive functionalities ensures its continued importance as a key intermediate in the development of advanced molecular structures. As research into quinoline-based compounds progresses, this specialized aldehyde derivative will undoubtedly play an increasingly significant role in scientific innovation.

Recommended suppliers
SHOCHEM(SHANGHAI) CO.,lTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
SHOCHEM(SHANGHAI) CO.,lTD
Wuhan ChemNorm Biotech Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Wuhan ChemNorm Biotech Co.,Ltd.
Shandong Jing Kun Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Jing Kun Chemical Co.,Ltd.
Wuhan Comings Biotechnology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Wuhan Comings Biotechnology Co., Ltd.
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.